1-9 of 9
sod1 gene
Close
Sort by
Journal Articles

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Haiping He, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuaki Yokoyama, MD PhD, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD, Tonghua Yang, MD PhD, Tokiko Nagamura-Inoue, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5011.
https://doi.org/10.1182/blood-2019-125046
Published: 2019
Journal Articles

Exploring the Mechanisms of Thalassemic Erythropoiesis Improvement Caused By Bone Marrow Tfr2 Deletion

Antonella Nai, PhD, Irene Artuso, MSc, Maria Rosa Lidonnici, PhD, Sandro Altamura, PhD, Giacomo Mandelli, PhD, Mariateresa Pettinato, MSc, Martina U. Muckenthaler, PhD, Laura Silvestri, PhD, Giuliana Ferrari, PhD, Clara Camaschella, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3624.
https://doi.org/10.1182/blood-2018-99-115835
Published: 2018
Journal Articles

Increased Longevity of Continuous Bone Marrow Cultures and Radioresistance of Bone Marrow Stromal Cells from SOD1 93A ALS (Amyotrophic Lateral Sclerosis) Mice

Andrew Henderson, Renee Fisher, Michael Epperly, PhD, Donna Shields, Lora Rigatti, Christopher Donnelly, Simon Watkins, Joel S. Greenberger, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5679.
https://doi.org/10.1182/blood-2018-99-113580
Published: 2018
Journal Articles

Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity

Ivan Cherh Chiet Low, Thomas Loh, Yiqing Huang, David M. Virshup, Shazib Pervaiz
Journal: Blood
Blood (2014) 124 (14): 2223–2234.
https://doi.org/10.1182/blood-2014-03-563296
Published: 2014
Includes: Supplemental data
Journal Articles

PP2A inactivation by ROS accumulation

Shingo Nakahata, Kazuhiro Morishita
Journal: Blood
Blood (2014) 124 (14): 2163–2165.
https://doi.org/10.1182/blood-2014-08-594093
Published: 2014
Journal Articles

Can Polymorphisms In Oxidative Stress Related Genes Be a Risk Factor For CML?

Ana Cristina Gonçalves, MSc, PhD, Raquel Alves, MSc, PhD, Paulo Freitas-Tavares, MD, Adriana Teixeira, MD, Luísa Mota-Vieira, PhD, José Manuel Nascimento-Costa, MD, PhD, Ana Bela Sarmento-Ribeiro, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5156.
https://doi.org/10.1182/blood.V122.21.5156.5156
Published: 2013
Journal Articles

Early Biomarkers for the Anti-Angiogenic and Anti-Tumor Activity of the Superoxide Dismutase 1 (SOD1) Inhibitor Tetrathiomolybdate.

M.J. Braunstein, E. Smith, C. Timucin, F. Doñate, J.C. Juarez, M. Burnett, M. Manuia, D.E. Shaw, A.P. Mazar, O. Batuman
Journal: Blood
Blood (2007) 110 (11): 4214.
https://doi.org/10.1182/blood.V110.11.4214.4214
Published: 2007
Journal Articles

Phase I Study of the [Cu, Zn] Superoxide Dismutase (SOD1) Inhibitor ATN-224 (Bis-Choline Tetrathiomolybdate) in Patients (pts) with Advanced Hematologic Malignancies.

James R. Berenson, MD, Ralph Vincent Boccia, MD, Asad Bashey, MD PhD, Alexandra M. Levine, MD, Omer N. Koc, MD, Jennifer A. Callahan, Andrew P. Mazar, PhD, Steven D. Reich, MD
Journal: Blood
Blood (2006) 108 (11): 2593.
https://doi.org/10.1182/blood.V108.11.2593.2593
Published: 2006
Journal Articles

Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase

Suzana Hadjur, Karen Ung, Louis Wadsworth, James Dimmick, Evica Rajcan-Separovic, Richard W. Scott, Manuel Buchwald, Frank R. Jirik
Journal: Blood
Blood (2001) 98 (4): 1003–1011.
https://doi.org/10.1182/blood.V98.4.1003
Published: 2001